Our findings demonstrated a marked increase in CLPTM1L mRNA expression levels in both HeLa and C33A cervical cancer cell lines, as well as in cervical carcinoma tissues, when compared to normal counterparts. Here, CLPTM1L is linked to cervical carcinoma.